Learn More
Cayman Chemical 1 2 3TrIdocosahexaenoyl Glyc

Supplier: Cayman Chemical 23152250 MG
A selective inhibitor of mutant EGFR that exhibits a 298-fold increase in potency compared with wild-type EGFR oral administration at 500 mg/kg regresses tumors with EGFR-active and T790M mutations in a xenograft model
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.